# Phase 5 backend integration approval gate

| Requirement | Status | Evidence | Remaining action |
|---|---|---|---|
| Feature flag defaults disabled | PASS | Settings parser; focused tests 1-5 | Keep disabled outside controlled review |
| Explicit genetic group supported | PASS | v2 schema and eligibility tests | Future UI needs deliberate exact-value input |
| Breed inference prohibited | PASS | Eligibility implementation and test 16 | Preserve in any future adapter |
| THI mapping implemented | PASS WITH LIMITATION | Exact formula/boundary tests and THI CSV | Numeric study weather overlap remains unresolved |
| Eligibility fails closed | PASS | Genetic, population, environment, THI tests | Preserve stable reason codes |
| Candidate hashes verified | PASS | Artifact integrity report and mismatch injection | Retain repository change control |
| DMI prediction isolated | PASS | Explicit unit/source/provenance; no ration path | No feed conversion without a new approval |
| Milk prediction isolated | PASS | Explicit source; independent task execution | Do not select a primary milk model automatically |
| No automatic fallback model | PASS | Partial/unavailable tests | Any future fallback needs named authorization |
| Nutrition rules unchanged | PASS | Protected hashes and mocked no-call test | None for Phase 5 |
| Existing v1 behavior preserved | PASS | v1 tests; `api/routes.py` protected hash | Continue regression coverage |
| Frontend unchanged | PASS | Protected frontend tree hash | Separate Phase 6 authorization required |
| PDF unchanged | PASS | Protected PDF-source hash | Separate authorization required |
| Tests pass | PASS | 56/56 focused; 307/307 complete | Re-run in review/CI environment |
| Production approval remains false | PASS | Contracts and metadata | External validation, deployment security, pinning and approval remain required |

## Recommendation

`READY_FOR_CONTROLLED_FRONTEND_INTEGRATION`

This means the disabled-by-default backend contract is ready for a separately
authorized, controlled Phase 6 review. It does not approve frontend work in
Phase 5, deployment, model promotion, commercial use, veterinary use, or
production enablement.
